PRESS RELEASE published on 02/28/2023 at 13:30, 3 years ago Moderna to Present at Cowen's 43rd Annual Health Care Conference
PRESS RELEASE published on 02/23/2023 at 13:00, 3 years ago Moderna Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Updates
PRESS RELEASE published on 02/22/2023 at 22:05, 3 years ago Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk Mela
PRESS RELEASE published on 02/22/2023 at 13:00, 3 years ago Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies
PRESS RELEASE published on 02/17/2023 at 17:00, 3 years 1 month ago Health Canada Authorizes Moderna's Omicron-Targeting Bivalent COVID-19 Vaccine in Children & Adolescents (6-17 Years)
PRESS RELEASE published on 02/16/2023 at 22:05, 3 years 1 month ago Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate
PRESS RELEASE published on 02/02/2023 at 13:00, 3 years 1 month ago Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023
PRESS RELEASE published on 01/30/2023 at 13:15, 3 years 1 month ago Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
PRESS RELEASE published on 01/17/2023 at 22:05, 3 years 2 months ago Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults
PRESS RELEASE published on 01/09/2023 at 13:00, 3 years 2 months ago Moderna Announces Advances Across mRNA Pipeline and Provides Business Update
Published on 03/18/2026 at 14:30, 32 minutes ago Ground Geophysics Underway at Murphy Lake, 5 km From Isoenergy's Hurricane Deposit, Athabasca Basin
Published on 03/18/2026 at 14:15, 47 minutes ago Apex Provides Phase I Drilling Update at the Rift Rare Earth Project in Nebraska, U.S.A.
Published on 03/18/2026 at 14:00, 1 hour 2 minutes ago Route1 Announces Filing of Parking Copilot Patent Application and Confirms Expected Launch Date for "Mr. Parking"
Published on 03/18/2026 at 14:00, 1 hour 2 minutes ago FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
Published on 03/18/2026 at 13:30, 1 hour 32 minutes ago Predictiv AI Launches AGORACOM Marketing Program and Engages Venture Liquidity Partners for Market Making
Published on 03/18/2026 at 14:25, 37 minutes ago Ethisphere recognizes Infosys among 2026 World's Most Ethical Companies®
Published on 03/18/2026 at 14:25, 37 minutes ago PSI postpones the release of its 2025 annual and consolidated financial statements until the end of April 2026
Published on 03/18/2026 at 14:19, 43 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/18/2026 at 07:00, 8 hours 2 minutes ago Mersen: A resilient performance in 2025, return to growth expected in 2026
Published on 03/17/2026 at 07:00, 1 day 8 hours ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day 21 hours ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day 21 hours ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day 21 hours ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
